Synthetically engineered bacteria destroys superbugs

By Admin
Share
Scientists in Singapore have engineered a ‘suicide bomber strain of bacteria which has the ability to destroy a common but deadly hospital superb...

Scientists in Singapore have engineered a ‘suicide bomber’ strain of bacteria which has the ability to destroy a common but deadly hospital superbug.

The researchers have taken a strain of E.Coli which is commonly present in the human gut and empowered it to recognise and kill the Pseudomonas aeruginosa bacteria.

Upon recognising the superbug the newly engineered bacteria produces a fatal toxin, before exploding to cover the entire area in the chemical.   

It is thought this is the first time a study has used synthetic biology to tackle an infectious diseases.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

Lab tests of the bacteria found it destroyed 99 percent of targets and it is now hoped it could be used to tackle drug-resistant superbugs and infections.  

Pseudomonas aeruginosa is often found in hospitals and targets patients with weakened immune systems.

The superbug can be fatal as it causes infections in any bodily tissues that it can attach itself too, including the lungs, guts and the bladder.

The results of the research have been published in the Molecular Systems Biology journal.

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare